Skip to search formSkip to main contentSkip to account menu

tolamolol

Known as: 4-(2-(2-hydroxy-3-o-tolyloxypropylamino)ethoxy)benzamide, totamidol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
The chiral resolution of some clinically used drugs namely metoprolol, teratolol, tolamolol, nebivolol (beta-adrenergic blockers… 
Highly Cited
1979
Highly Cited
1979
We compared the immediate effects of five beta-adrenoreceptor-blocking agents in 16 patients with stable angina pectoris. Acute… 
1979
1979
Abstract 1 Four groups of patients with previously untreated essential hypertension in WHO stage I were treated either with… 
1977
1977
1 Twelve men with untreated essential hypertension in WHO stage I were studied on an outpatient basis to evaluate the… 
Highly Cited
1976
Highly Cited
1976
  • H. H. Harms
  • The Journal of pharmacology and experimental…
  • 1976
  • Corpus ID: 26398029
pA2 values against isoproterenol were determined for a number of cardioselective and noncardioselective beta adrenergic receptor… 
Highly Cited
1976
Highly Cited
1976
The effects of single oral doses of the cardioselective beta adrenoceptor blocking drugs, metoprolol and tolamolol, on specific… 
1975
1975
Forty-two patients with angina pectoris have completed a randomized, double-blind trial comparing tolamolol 100 mg and 200 mg… 
1975
1975
Pharmacokinetic and physiological variables were measured in six healthy subjects after intravenous and oral administration of… 
1973
1973
Orally administered tolamolol, a new cardioselective beta-adrenergic blocking drug, was evaluated in 30 patients with…